HLS Therapeutics 2018 Spring Investor Presentation

HLS Therapeutics investor presentation showcasing the company's specialty pharma strategy and track record of value creation. The presentation highlights the management team's achievements, including a $2.5B exit value and 145% return in 30 months through operational improvements, cost reductions, and strategic implementation.